Faith Susan Lang, LCSW | |
280 Route 211 E Ste 7, Middletown, NY 10940-3100 | |
(845) 341-8493 | |
(845) 258-4611 |
Full Name | Faith Susan Lang |
---|---|
Gender | Female |
Speciality | Clinical Social Worker |
Experience | 20 Years |
Location | 280 Route 211 E Ste 7, Middletown, New York |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114174323 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | SW16540 (Florida) | Secondary |
101YA0400X | Counselor - Addiction (substance Use Disorder) | 078115 (New York) | Primary |
Mailing Address | Practice Location Address |
---|---|
Faith Susan Lang, LCSW 280 Route 211 E Ste 7, Middletown, NY 10940-3100 Ph: (845) 341-8493 | Faith Susan Lang, LCSW 280 Route 211 E Ste 7, Middletown, NY 10940-3100 Ph: (845) 341-8493 |
News Archive
A program that bundled two generic, low-cost drugs - a cholesterol-lowering statin and a blood pressure-lowering drug - and gave daily doses to 68,560 people with diabetes or heart disease for two years is estimated to have prevented 1,271 heart attacks and strokes in the first year following the study period, according to a Kaiser Permanente study published online in the American Journal of Managed Care.
Jennifer Matton is going to college for the third time, no easy thing with a job, church groups and four children with activities from lacrosse to Boy Scouts. She always planned to return to school, but as it turned out, she had little choice: her career depended on it. Ms. Matton, a nurse, works at Abington Memorial Hospital, one of hundreds around the country that have started to require that their nurses have at least a bachelor's degree in nursing.
Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that a Phase 2 study of orally administered interferon-alpha for the prevention of influenza and winter colds has reached the midway point. The study in Perth, Australia achieved full target enrollment of 200 subjects and 98% of the subjects remain on study drug. Subjects in the study are receiving a lozenge containing interferon-alpha or a matching placebo once a day for 16 weeks.
The Consortium for Southeastern Hypertension Control (COSEHC), which is headquartered at Wake Forest University Baptist Medical Center, has received a $55,000 grant from the Blue Cross and Blue Shield of North Carolina Foundation to provide a mobile cardiovascular disease prevention program, Hypertension on Wheels, to Forsyth County residents.
A new type of drug originally developed for lung cancer can reduce the size of breast cancer tumours when taken in combination with other drugs.
› Verified 2 days ago